Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AVONEX for moderate to severe ulcerative colitis
2007-004867-22Phase 2Completed
- Sponsor
- Biogen
- Start
- Feb 2008
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in autoimmune colitis comparing AVONEX with Placebo (2 arms). Primary endpoint: Clinical response at Week 8. Started Feb 2008; status: completed.
02
Drugs
interferon beta-1a
03
Conditions
autoimmune colitis
Beyond the preview
Go deeper on 2007-004867-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-004867-22.